Multiple sclerosis: risk factors, prodromes, and potential causal pathways
- PMID: 20610348
- DOI: 10.1016/S1474-4422(10)70094-6
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Abstract
Multiple sclerosis (MS) is a common, complex neurological disease. The precise aetiology of MS is not yet known, although epidemiological data indicate that both genetic and environmental factors are important. The evidence that the environment acts long before MS becomes clinically evident is well established and suggests the existence of a prodromal phase for the disease. The increasing incidence of MS emphasises the need for strategies to prevent this chronic disorder, and the possibility of a prodrome indicates a window of opportunity to potentially reverse early disease processes before clinical disease becomes evident. Studying a prodrome requires techniques other than clinical observation such as monitoring endophenotypes that result from associated risk factors. However, our current knowledge of causal pathways and endophenotypes in MS is limited. Identifying and studying individuals with a high risk of developing the disease provides a powerful opportunity to understand the MS causal cascade and is highly relevant to strategies that are aimed at preventing this debilitating disease.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Environmental factors and their timing in adult-onset multiple sclerosis.Nat Rev Neurol. 2010 Mar;6(3):156-66. doi: 10.1038/nrneurol.2010.1. Epub 2010 Feb 16. Nat Rev Neurol. 2010. PMID: 20157307 Review.
-
The causal cascade to multiple sclerosis: a model for MS pathogenesis.PLoS One. 2009;4(2):e4565. doi: 10.1371/journal.pone.0004565. Epub 2009 Feb 26. PLoS One. 2009. PMID: 19242548 Free PMC article.
-
The epidemiology of multiple sclerosis: insights to a causal cascade.Handb Clin Neurol. 2016;138:173-206. doi: 10.1016/B978-0-12-802973-2.00011-2. Handb Clin Neurol. 2016. PMID: 27637959 Review.
-
The nature of genetic and environmental susceptibility to multiple sclerosis.PLoS One. 2021 Mar 22;16(3):e0246157. doi: 10.1371/journal.pone.0246157. eCollection 2021. PLoS One. 2021. PMID: 33750973 Free PMC article.
-
Genes, environment, and susceptibility to multiple sclerosis.Neurobiol Dis. 2004 Nov;17(2):131-43. doi: 10.1016/j.nbd.2004.07.015. Neurobiol Dis. 2004. PMID: 15474351 Review.
Cited by
-
COVID-19 illness and autoimmune diseases: recent insights.Inflamm Res. 2021 Apr;70(4):407-428. doi: 10.1007/s00011-021-01446-1. Epub 2021 Feb 28. Inflamm Res. 2021. PMID: 33640999 Free PMC article. Review.
-
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.PLoS One. 2016 Mar 31;11(3):e0152347. doi: 10.1371/journal.pone.0152347. eCollection 2016. PLoS One. 2016. PMID: 27032105 Free PMC article.
-
Online Social Support for Patients with Multiple Sclerosis: A Thematic Analysis of Messages Posted to a Virtual Support Community.Int J Community Based Nurs Midwifery. 2016 Jul;4(3):188-98. Int J Community Based Nurs Midwifery. 2016. PMID: 27382585 Free PMC article.
-
Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions.Front Aging Neurosci. 2018 Aug 21;10:254. doi: 10.3389/fnagi.2018.00254. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30186153 Free PMC article.
-
Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions.Front Genet. 2018 Dec 17;9:647. doi: 10.3389/fgene.2018.00647. eCollection 2018. Front Genet. 2018. PMID: 30619471 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical